Skip to main content

Table 1 Previously reported CML cases with five-way translocations and the present case

From: A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report

Case no. Age/Sex Karyotype of five-way translocation Reference no. Treatment Outcome
1 10/Male t(4;18;13;9;22)(q12;q11.2;q14;q34;q11.2) [1] BSF Died 81months
2 23/Male t(9;22;15;19;10) [2] Not reported Not reported
3 68/Not reported t(3;4;9;11;22) [3] Not reported Died in benign phase
4 64/Female t(9;22;21;11;inv ins(12)(q15p12p13)(q34;q11;q22;q13;q15) [4] BSF/VCR and PSL/ADM, CPA and MTX Died 33 months
5 63/Male t(9;22;10;12;1)(q34;q11.2;q22;p12;p36.1) [5] DNR,VCR,AND and PSL Died 34 months
6 68/Female t(9;22;15;13;17)(q34;q11;q26;q14;q11) [6] Chemotherapy Not reported
7 Not reported/Male t(2;9;16;22;22)(q32;q34;q21;q11;q11) [7] Not reported Not reported
8 32/Male t(4;12;7;9;22)(q33?;q24;p13;q34;q11) [8] GLI 41 months
9 45/Female t(1;4;5;9;22)(q42;p14;q31;q34;q11.2) [9] HU/GLI 62 months
10 58/Male t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) The present case GLI 44 months
  1. BSF:Busulphan, VCR:Vincristine, PSL: Prednisolone, ADM:Adriamycin, CPA:Cyclophosphamide, MTX:Methotrexate, DNR:Daunorubicin, GLI:Imatinib, HU:Hydroxyurea.